Pal Maurovich-Horvat
Biographic Data
| ID | 9018929 |
|---|---|
| NAME | Pal Maurovich-Horvat |
| GIVEN NAMES | Pal |
| FAMILY NAME | Maurovich-Horvat |
| SIGNATURE | MAUROVICH-HORVAT P |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Long-term survival benefit of male and multimorbid Covid-19 patients with 5-day remdesivir treatment
Background: Treatment of the coronavirus disease (COVID-19) is still challenging due to the lack of evidence-based treatment protocols and continuously changing epidemiological situations and vaccinations. Remdesivir (RDV) is among the few antiviral medications with confirmed efficacy for specific patient groups. However, real-world data on long-term outcomes for a short treatment course are scarce. Methods: This retrospective observational cohor…
No prominent works on this page.
Long-term survival benefit of male and multimorbid Covid-19 patients with 5-day remdesivir treatment
Background: Treatment of the coronavirus disease (COVID-19) is still challenging due to the lack of evidence-based treatment protocols and continuously changing epidemiological situations and vaccinations. Remdesivir (RDV) is among the few antiviral medications with confirmed efficacy for specific patient groups. However, real-world data on long-term outcomes for a short treatment course are scarce. Methods: This retrospective observational cohor…
Cohort study (1 work) · Comorbidity (1 work) · COPD (1 work) · COVID-19 Clinical Research Studies (1 work) · Diabetes mellitus (1 work) · Epidemiology (1 work) · Internal Medicine (1 work) · Medicine (1 work) · Pharmacological Receptor Mechanisms and Effects (1 work) · Propensity score matching (1 work)